Institutional Ownership
Travere Therapeutics Inc
CUSIP 89422G107COMTVTXQ1 2026
13D / 13G Filings
74
Schedule 13D/13G on record
Beneficial Filers
23
Distinct reporting persons
Largest Stake
12.8%
Max % of class reported
Institutional Holders
254
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
74 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Perceptive Advisors LLC | 13G/A | 4.8% | 4.28M | SEC |
| 2 | Feb 17, 2026 | Armistice Capital, LLC | 13G/A | 4.2% | 3.76M | SEC |
| 3 | Feb 13, 2026 | Macquarie Group Limited | 13G/A | — | — | SEC |
| 4 | Feb 9, 2026 | State Street Corporation | 13G | 5.3% | 4.76M | SEC |
| 5 | Jan 8, 2026 | Fmr LLC | 13G | 11.7% | 10.57M | SEC |
| 6 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 11.9% | 10.60M | SEC |
| 7 | Nov 14, 2025 | Armistice Capital, LLC | 13G/A | 7.5% | 6.72M | SEC |
| 8 | Oct 14, 2025 | Perceptive Advisors LLC | 13G | 5.5% | 4.90M | SEC |
| 9 | Aug 7, 2025 | Janus Henderson Group PLC | 13G/A | 12.8% | 11.34M | SEC |
| 10 | Jul 29, 2025 | The Vanguard Group | 13G/A | 6.7% | 5.99M | SEC |
64 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Travere Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 11.42M | $339.25M |
| 2 | Fmr LLC | 10.97M | $325.86M |
| 3 | Blackrock, Inc. | 7.79M | $231.50M |
| 4 | State Street Corp | 4.96M | $147.36M |
| 5 | Armistice Capital, LLC | 4.90M | $145.50M |
| 6 | Perceptive Advisors LLC | 4.14M | $123.08M |
| 7 | Nomura Asset Management International Inc. | 3.27M | $97.17M |
| 8 | Geode Capital Management, LLC | 2.37M | $70.41M |
| 9 | Renaissance Technologies LLC | 1.97M | $58.43M |
| 10 | Stephens Investment Management Group LLC | 1.80M | $53.43M |